CSL granted Eli Lilly certain rights for clazakizumab CSl to receive upfront payment of $100 million CSL shares up 2.1% CSL will retain exclusive rights to develop and commercialise clazakizumab for ...

Eli Lilly & CSL seal a deal for clazakizumab partitions rights to maximize lifecycle value. CSL retains ESKD focus as Lilly prioritizes commercialization. CSL and Eli Lilly have struck a strategic ...

Exclusive licensing grants Lilly development and commercialization rights for clazakizumab beyond ESKD-related cardiovascular prevention, while CSL retains the ESKD cardiovascular events indication.

Feb 18 (Reuters) - Australia's CSL said on Wednesday it had entered into ‌an exclusive licensing agreement with ‌Eli Lilly and Co, granting it certain rights to develop and commercialise clazakizumab, ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

Ord Minnett sees one as a buy and one to hold. CSL shares have come under heavy scrutiny recently. Investors have been exiting their positions in the company following its half year earnings results.

(Corrects headline to remove incorrect reference to CSL licensing Eli Lilly's clazakizumab) Feb 18 (Reuters) - Australia's CSL said on Wednesday it had entered into an exclusive licensing agreement ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

With the Connected Battlefield Universe's development now in full swing, EA announced today that Battlefield 2042 Season 7 will officially be its last. Writing in a blog, Battlefield general manager ...

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring ...